GRACIOUS
01 Jan 18
GRACIOUS Grouping, Read-Across, Characterisation and Classification Framework for Regulatory Risk Assessment of Manufactured Nanomaterials and Safer Design of nano-enabled Products
GRACIOUS Grouping, Read-Across, Characterisation and Classification Framework for Regulatory Risk Assessment of Manufactured Nanomaterials and Safer Design of nano-enabled Products
COMBOEPOC Exploration and Proof of Concept of the efficacy of combined treatment with ORY-1001 in oncological indications ABSTRACT The treatment
CALS100 Automated analytical system based on fecal biomarkers for the diagnosis of intestinal inflammatory diseases ABSTRACT The main objective of
PRECLINONCO Preclinical regulatory development of new oncological drug candidates ABSTRACT The PRECLINONCO project pursues the main objective of obtaining the
HelloAI Healthcare UPgraded – role of Artificial Intelligence in Healthcare www.helloai.info Today, a perfect storm of economic, demographic, technological, and
On the 12th of December, the Instituto de Investigación Sanitaria La Fe, located in Valencia, is organising a Health Summit
The EIT Health Summit is an annual opportunity for our world-leading consortium to unite in the cause of promoting healthcare
AMI Antidrug-antibody and drug Molecular detection in Inflammatory diseases with organic electronics platform Autoimmune diseases are characterized by a deregulation
The RIS3CAT Intercommunitats Forum brings together the different members of the RIS3CAT Communities from the 2015 call. It took place
On November 23, the HealthTech Cluster organizes its annual meeting among all the agents in the value chain of the
OACTIVE Advanced personalised, multi-scale computer models preventing OsteoArthritis oactive.eu Osteoarthritis (OA) is a degenerative disease of the articular cartilage
In January 2018, LEITAT will become a core member of EIT Health, upgrading its current membership. LEITAT will join other
From the 17th to the 19th of October, the ETPN2017 Annual Event took place in Malaga. Our health expert attended
On the 16th and 17th of October, the nTRACK consortium met for the first time in Barcelona for the kickoff
On August 21st, the oncology team led by Dr. Jose Luis Hernandez from the Health & Biomedicine Unit published a
nTRACK Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration www.n-track.eu Cell therapy offers promising
Phone. (+34) 937 882 300
